Global 0.9% Sodium Chloride Injection Market Growth 2025-2031
Description
The global 0.9% Sodium Chloride Injection market size is predicted to grow from US$ 13660 million in 2025 to US$ 18730 million in 2031; it is expected to grow at a CAGR of 5.4% from 2025 to 2031.
Sodium chloride is an electrolyte supplement. Sodium and chlorine are important electrolytes in the body, which mainly exist in the extracellular fluid and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid. The concentration of normal serum Na+is 135~145mmol/L, accounting for 92% of plasma cation and 90% of total osmotic pressure. Therefore, the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum Cl - concentration is 98 ～ 106mmol/L. Sodium and chloride ions in human body are mainly regulated by hypothalamus, posterior pituitary and kidney to maintain the stability of body fluid volume and osmotic pressure. The injection concentration is usually 0.9%. This report studies the 0.9% concentration of sodium chloride injection.
United States market for 0.9% Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for 0.9% Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for 0.9% Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key 0.9% Sodium Chloride Injection players cover Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., SSY Group Limited, Jiangsu Sihuan Bioengineering Co.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “0.9% Sodium Chloride Injection Industry Forecast” looks at past sales and reviews total world 0.9% Sodium Chloride Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected 0.9% Sodium Chloride Injection sales for 2025 through 2031. With 0.9% Sodium Chloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 0.9% Sodium Chloride Injection industry.
This Insight Report provides a comprehensive analysis of the global 0.9% Sodium Chloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 0.9% Sodium Chloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 0.9% Sodium Chloride Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 0.9% Sodium Chloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 0.9% Sodium Chloride Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of 0.9% Sodium Chloride Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100ml
250ml
500ml
Other
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
SSY Group Limited
Jiangsu Sihuan Bioengineering Co.,Ltd.
China Resources Double-crane Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Anhui Changjiang Pharmaceutical Co., Ltd.
PKU HealthCare Corp.,Ltd.
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Pfizer
Amphastar
AstraZeneca plc.
Fresenius Kabi
Baxter
Otsuka Pharmaceutical
Novartis
BBraun
Huaren Pharmaceutical Co.,Ltd.
Jilin Province Dubang Pharmaceuticals Co., Ltd.
Jiangsu Suzhong PHARMA Group Co., Ltd.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical Co., Ltd.
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global 0.9% Sodium Chloride Injection market?
What factors are driving 0.9% Sodium Chloride Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 0.9% Sodium Chloride Injection market opportunities vary by end market size?
How does 0.9% Sodium Chloride Injection break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Sodium chloride is an electrolyte supplement. Sodium and chlorine are important electrolytes in the body, which mainly exist in the extracellular fluid and play a very important role in maintaining the normal volume and osmotic pressure of blood and extracellular fluid. The concentration of normal serum Na+is 135~145mmol/L, accounting for 92% of plasma cation and 90% of total osmotic pressure. Therefore, the amount of plasma sodium plays a decisive role in osmotic pressure. The normal serum Cl - concentration is 98 ～ 106mmol/L. Sodium and chloride ions in human body are mainly regulated by hypothalamus, posterior pituitary and kidney to maintain the stability of body fluid volume and osmotic pressure. The injection concentration is usually 0.9%. This report studies the 0.9% concentration of sodium chloride injection.
United States market for 0.9% Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for 0.9% Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for 0.9% Sodium Chloride Injection is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key 0.9% Sodium Chloride Injection players cover Sichuan Kelun Pharmaceutical Co.,Ltd., Hangzhou Minsheng Pharmaceutical Co., Ltd., Jiangsu Hengrui Pharmaceuticals Co.,ltd., SSY Group Limited, Jiangsu Sihuan Bioengineering Co.,Ltd., etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LP Information, Inc. (LPI) ' newest research report, the “0.9% Sodium Chloride Injection Industry Forecast” looks at past sales and reviews total world 0.9% Sodium Chloride Injection sales in 2024, providing a comprehensive analysis by region and market sector of projected 0.9% Sodium Chloride Injection sales for 2025 through 2031. With 0.9% Sodium Chloride Injection sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world 0.9% Sodium Chloride Injection industry.
This Insight Report provides a comprehensive analysis of the global 0.9% Sodium Chloride Injection landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyzes the strategies of leading global companies with a focus on 0.9% Sodium Chloride Injection portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global 0.9% Sodium Chloride Injection market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for 0.9% Sodium Chloride Injection and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global 0.9% Sodium Chloride Injection.
This report presents a comprehensive overview, market shares, and growth opportunities of 0.9% Sodium Chloride Injection market by product type, application, key manufacturers and key regions and countries.
Segmentation by Type:
100ml
250ml
500ml
Other
Segmentation by Application:
Hospitals
Clinics
Others
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analysing the company's coverage, product portfolio, its market penetration.
Sichuan Kelun Pharmaceutical Co.,Ltd.
Hangzhou Minsheng Pharmaceutical Co., Ltd.
Jiangsu Hengrui Pharmaceuticals Co.,ltd.
SSY Group Limited
Jiangsu Sihuan Bioengineering Co.,Ltd.
China Resources Double-crane Pharmaceutical Co.,Ltd.
Sichuan Biokin Pharmaceutical Co.,Ltd.
Anhui Fengyuan Pharmaceutical Co.,Ltd.
Cisen Pharmaceutical
Tonghua Golden-horse Pharmaceutical Industry Co.,ltd.
Anhui Changjiang Pharmaceutical Co., Ltd.
PKU HealthCare Corp.,Ltd.
CHENGDU BRILLIANT PHARMACEUTICAL CO., LTD.
Hebei TIANCHENG Pharmaceutical Co., Ltd.
Southwest Pharmaceutical Co., Ltd.
Pfizer
Amphastar
AstraZeneca plc.
Fresenius Kabi
Baxter
Otsuka Pharmaceutical
Novartis
BBraun
Huaren Pharmaceutical Co.,Ltd.
Jilin Province Dubang Pharmaceuticals Co., Ltd.
Jiangsu Suzhong PHARMA Group Co., Ltd.
Nanjing Zhengda Tianqing Pharmaceutical Co., Ltd.
Shandong Weigao Pharmaceutical Co., Ltd.
Shanghai Fosun Pharmaceutical(Group)Co.,Ltd.
Key Questions Addressed in this Report
What is the 10-year outlook for the global 0.9% Sodium Chloride Injection market?
What factors are driving 0.9% Sodium Chloride Injection market growth, globally and by region?
Which technologies are poised for the fastest growth by market and region?
How do 0.9% Sodium Chloride Injection market opportunities vary by end market size?
How does 0.9% Sodium Chloride Injection break out by Type, by Application?
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
181 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
- 1 Scope of the Report
- 2 Executive Summary
- 3 Global by Company
- 4 World Historic Review for 0.9% Sodium Chloride Injection by Geographic Region
- 5 Americas
- 6 APAC
- 7 Europe
- 8 Middle East & Africa
- 9 Market Drivers, Challenges and Trends
- 10 Manufacturing Cost Structure Analysis
- 11 Marketing, Distributors and Customer
- 12 World Forecast Review for 0.9% Sodium Chloride Injection by Geographic Region
- 13 Key Players Analysis
- 14 Research Findings and Conclusion
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
